¥2,772.00 ($17.56)

+5.00 (+0.18%)

Weekly Expected Move ±2.0%

¥2660 ¥2716 ¥2772 ¥2828 ¥2884

JPX · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 34 · ¥40.1B mcap · 6M float · 0.039% daily turnover

Revenue

$22.6B +3.2% ▲

5Y CAGR: +2.5%

Gross Profit

$8.3B -4.8% ▼

5Y CAGR: +0.6%

Operating Income

$4.5B -4.1% ▼

5Y CAGR: +0.7%

Net Income

$3.0B -1.8% ▼

5Y CAGR: +0.9%

EPS (Diluted)

$204.55 +8.8% ▲

5Y CAGR: +3.7%

EBITDA

$6.4B +0.6% ▲

5Y CAGR: +2.4%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$19.3B	$20.1B	$21.6B	$21.9B	$22.6B
YoY Growth	-2.9%	+4.2%	+7.3%	+1.1%	+3.2%
Cost of Revenue	$11.7B	$11.9B	$13.3B	$13.1B	$14.2B
Gross Profit	$7.6B	$8.2B	$8.3B	$8.8B	$8.3B
Gross Margin	39.3%	40.6%	38.5%	40.1%	36.9%
R&D Expenses	$357M	$327M	$323M	$278M	$272M
SG&A Expenses	$3.6B	$3.5B	$3.9B	$3.7B	$3.6B
Operating Expenses	$3.8B	$3.8B	$4.2B	$4.1B	$3.8B
Operating Income	$3.8B	$4.4B	$4.1B	$4.7B	$4.5B
Operating Margin	19.6%	22.0%	19.1%	21.4%	19.9%
Interest Expense	$7M	$7M	$8M	$8M	$8M
Income Before Tax	$3.9B	$4.5B	$4.3B	$4.8B	$4.7B
Tax Expense	$1.3B	$1.5B	$1.4B	$1.7B	$1.6B
Net Income	$2.7B	$3.0B	$2.9B	$3.1B	$3.0B
Net Margin	13.8%	14.9%	13.3%	14.0%	13.4%
EPS (Diluted)	$157.36	$178.14	$170.67	$187.95	$204.55
EBITDA	$5.2B	$5.8B	$5.6B	$6.3B	$6.4B
Shares Outstanding	17M	17M	17M	16M	15M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$5.7B	$6.1B	$5.2B	$5.9B	$6.0B	$6.5B	$5.3B	$6.4B
Cost of Revenue	$3.5B	$3.6B	$3.5B	$3.7B	$3.7B	$4.0B	$3.9B	$4.0B
Gross Profit	$2.2B	$2.5B	$1.7B	$2.2B	$2.3B	$2.6B	$1.4B	$2.4B
Gross Margin	38.1%	40.7%	33.2%	36.7%	38.3%	39.6%	25.9%	37.7%
R&D Expenses	$0	$0	$271M	$0	$0	$0	$0	$0
SG&A Expenses	$1.0B	$1.1B	$874M	$1.1B	$1.1B	$1.2B	$763M	$1.1B
Operating Expenses	$1.0B	$1.1B	$874M	$1.1B	$1.1B	$1.2B	$763M	$1.1B
Operating Income	$1.1B	$1.4B	$857M	$1.0B	$1.2B	$1.4B	$614M	$1.3B
Operating Margin	20.2%	23.3%	16.4%	17.4%	20.2%	21.6%	11.6%	19.9%
Interest Expense	$0	-$6M	$0	$2M	$2M	$2M	$2M	$2M
Income Before Tax	$1.2B	$1.4B	$956M	$1.1B	$1.3B	$1.5B	$687M	$1.3B
Tax Expense	$300M	$546M	$98M	$703M	$306M	$579M	-$82M	$777M
Net Income	$873M	$877M	$858M	$392M	$959M	$886M	$769M	$523M
Net Margin	15.4%	14.5%	16.5%	6.7%	15.9%	13.5%	14.5%	8.2%
EPS (Diluted)	$58.96	$59.67	$58.65	$26.83	$65.57	$60.88	$53.09	$36.15
EBITDA	$1.6B	$1.8B	$1.5B	$1.5B	$1.8B	$1.9B	$1.2B	$1.8B
Shares Outstanding	15M	15M	15M	15M	15M	15M	14M	14M

7749.T JPX